Mosquito Repellents Market

ID: MRFR/CG/5902-HCR 128 Pages Pradeep Nandi Last Updated: September 15, 2026
Mosquito Repellents Market Size, Share, Industry Trend & Analysis Research Report: By Product Type (Sprays, Creams, Lotions, Granules), By Active Ingredients (DEET, Picaridin, IR3535, Oil of Lemon Eucalyptus), By Formulation (Chemical, Natural, Biopesticides), By End Use (Household, Commercial, Agricultural) andBy Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa)- Forecast to 2035
Mosquito Repellents Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)4.76%
2024 Market Size$ 4.79 Billion
2025 Market Size$ 5.02 Billion
2035 Market Size$ 7.99 Billion
Key Players
SC Johnson
Reckitt Benckiser
Bayer
Spectrum Brands
Godrej Consumer Products
Mortein
Opportunities
  • Regulatory Support and Initiatives
  • Expansion of Outdoor Activities and Travel
  • Increased Consumer Awareness and Education
  1. SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS |
    1. 1.1 EXECUTIVE SUMMARY | |
      1. 1.1.1 Market Overview | |
      2. 1.1.2 Key Findings | |
      3. 1.1.3 Market Segmentation | |
      4. 1.1.4 Competitive Landscape | |
      5. 1.1.5 Challenges and Opportunities | |
      6. 1.1.6 Future Outlook 2
  2. SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE |
    1. 2.1 MARKET INTRODUCTION | |
      1. 2.1.1 Definition | |
      2. 2.1.2 Scope of the study | | |
        1. 2.1.2.1 Research Objective | | |
        2. 2.1.2.2 Assumption | | |
        3. 2.1.2.3 Limitations |
    2. 2.2 RESEARCH METHODOLOGY | |
      1. 2.2.1 Overview | |
      2. 2.2.2 Data Mining | |
      3. 2.2.3 Secondary Research | |
      4. 2.2.4 Primary Research | | |
        1. 2.2.4.1 Primary Interviews and Information Gathering Process | | |
        2. 2.2.4.2 Breakdown of Primary Respondents | |
      5. 2.2.5 Forecasting Model | |
      6. 2.2.6 Market Size Estimation | | |
        1. 2.2.6.1 Bottom-Up Approach | | |
        2. 2.2.6.2 Top-Down Approach | |
      7. 2.2.7 Data Triangulation | |
      8. 2.2.8 Validation 3
  3. SECTION III: QUALITATIVE ANALYSIS |
    1. 3.1 MARKET DYNAMICS | |
      1. 3.1.1 Overview | |
      2. 3.1.2 Drivers | |
      3. 3.1.3 Restraints | |
      4. 3.1.4 Opportunities |
    2. 3.2 MARKET FACTOR ANALYSIS | |
      1. 3.2.1 Value chain Analysis | |
      2. 3.2.2 Porter's Five Forces Analysis | | |
        1. 3.2.2.1 Bargaining Power of Suppliers | | |
        2. 3.2.2.2 Bargaining Power of Buyers | | |
        3. 3.2.2.3 Threat of New Entrants | | |
        4. 3.2.2.4 Threat of Substitutes | | |
        5. 3.2.2.5 Intensity of Rivalry | |
      3. 3.2.3 COVID-19 Impact Analysis | | |
        1. 3.2.3.1 Market Impact Analysis | | |
        2. 3.2.3.2 Regional Impact | | |
        3. 3.2.3.3 Opportunity and Threat Analysis 4
  4. SECTION IV: QUANTITATIVE ANALYSIS |
    1. 4.1 Consumer and Retail, BY Type (USD Billion) | |
      1. 4.1.1 Sprays | |
      2. 4.1.2 Creams | |
      3. 4.1.3 Lotions | |
      4. 4.1.4 Granules |
    2. 4.2 Consumer and Retail, BY Active Ingredients (USD Billion) | |
      1. 4.2.1 DEET | |
      2. 4.2.2 Picaridin | |
      3. 4.2.3 IR3535 | |
      4. 4.2.4 Oil of Lemon Eucalyptus |
    3. 4.3 Consumer and Retail, BY Formulation (USD Billion) | |
      1. 4.3.1 Chemical | |
      2. 4.3.2 Natural | |
      3. 4.3.3 Biopesticides |
    4. 4.4 Consumer and Retail, BY End Use (USD Billion) | |
      1. 4.4.1 Household | |
      2. 4.4.2 Commercial | |
      3. 4.4.3 Agricultural |
    5. 4.5 Consumer and Retail, BY Region (USD Billion) | |
      1. 4.5.1 North America | | |
        1. 4.5.1.1 US | | |
        2. 4.5.1.2 Canada | |
      2. 4.5.2 Europe | | |
        1. 4.5.2.1 Germany | | |
        2. 4.5.2.2 UK | | |
        3. 4.5.2.3 France | | |
        4. 4.5.2.4 Russia | | |
        5. 4.5.2.5 Italy | | |
        6. 4.5.2.6 Spain | | |
        7. 4.5.2.7 Rest of Europe | |
      3. 4.5.3 APAC | | |
        1. 4.5.3.1 China | | |
        2. 4.5.3.2 India | | |
        3. 4.5.3.3 Japan | | |
        4. 4.5.3.4 South Korea | | |
        5. 4.5.3.5 Malaysia | | |
        6. 4.5.3.6 Thailand | | |
        7. 4.5.3.7 Indonesia | | |
        8. 4.5.3.8 Rest of APAC | |
      4. 4.5.4 South America | | |
        1. 4.5.4.1 Brazil | | |
        2. 4.5.4.2 Mexico | | |
        3. 4.5.4.3 Argentina | | |
        4. 4.5.4.4 Rest of South America | |
      5. 4.5.5 MEA | | |
        1. 4.5.5.1 GCC Countries | | |
        2. 4.5.5.2 South Africa | | |
        3. 4.5.5.3 Rest of MEA 5
  5. SECTION V: COMPETITIVE ANALYSIS |
    1. 5.1 Competitive Landscape | |
      1. 5.1.1 Overview | |
      2. 5.1.2 Competitive Analysis | |
      3. 5.1.3 Market share Analysis | |
      4. 5.1.4 Major Growth Strategy in the Consumer and Retail | |
      5. 5.1.5 Competitive Benchmarking | |
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Consumer and Retail | |
      7. 5.1.7 Key developments and growth strategies | | |
        1. 5.1.7.1 New Product Launch/Service Deployment | | |
        2. 5.1.7.2 Merger & Acquisitions | | |
        3. 5.1.7.3 Joint Ventures | |
      8. 5.1.8 Major Players Financial Matrix | | |
        1. 5.1.8.1 Sales and Operating Income | | |
        2. 5.1.8.2 Major Players R&D Expenditure. 2023 |
    2. 5.2 Company Profiles | |
      1. 5.2.1 SC Johnson (US) | | |
        1. 5.2.1.1 Financial Overview | | |
        2. 5.2.1.2 Products Offered | | |
        3. 5.2.1.3 Key Developments | | |
        4. 5.2.1.4 SWOT Analysis | | |
        5. 5.2.1.5 Key Strategies | |
      2. 5.2.2 Reckitt Benckiser (GB) | | |
        1. 5.2.2.1 Financial Overview | | |
        2. 5.2.2.2 Products Offered | | |
        3. 5.2.2.3 Key Developments | | |
        4. 5.2.2.4 SWOT Analysis | | |
        5. 5.2.2.5 Key Strategies | |
      3. 5.2.3 Bayer (DE) | | |
        1. 5.2.3.1 Financial Overview | | |
        2. 5.2.3.2 Products Offered | | |
        3. 5.2.3.3 Key Developments | | |
        4. 5.2.3.4 SWOT Analysis | | |
        5. 5.2.3.5 Key Strategies | |
      4. 5.2.4 Spectrum Brands (US) | | |
        1. 5.2.4.1 Financial Overview | | |
        2. 5.2.4.2 Products Offered | | |
        3. 5.2.4.3 Key Developments | | |
        4. 5.2.4.4 SWOT Analysis | | |
        5. 5.2.4.5 Key Strategies | |
      5. 5.2.5 Godrej Consumer Products (IN) | | |
        1. 5.2.5.1 Financial Overview | | |
        2. 5.2.5.2 Products Offered | | |
        3. 5.2.5.3 Key Developments | | |
        4. 5.2.5.4 SWOT Analysis | | |
        5. 5.2.5.5 Key Strategies | |
      6. 5.2.6 Mortein (AU) | | |
        1. 5.2.6.1 Financial Overview | | |
        2. 5.2.6.2 Products Offered | | |
        3. 5.2.6.3 Key Developments | | |
        4. 5.2.6.4 SWOT Analysis | | |
        5. 5.2.6.5 Key Strategies | |
      7. 5.2.7 Cutter (US) | | |
        1. 5.2.7.1 Financial Overview | | |
        2. 5.2.7.2 Products Offered | | |
        3. 5.2.7.3 Key Developments | | |
        4. 5.2.7.4 SWOT Analysis | | |
        5. 5.2.7.5 Key Strategies | |
      8. 5.2.8 Thermacell (US) | | |
        1. 5.2.8.1 Financial Overview | | |
        2. 5.2.8.2 Products Offered | | |
        3. 5.2.8.3 Key Developments | | |
        4. 5.2.8.4 SWOT Analysis | | |
        5. 5.2.8.5 Key Strategies | |
      9. 5.2.9 Pest Control (US) | | |
        1. 5.2.9.1 Financial Overview | | |
        2. 5.2.9.2 Products Offered | | |
        3. 5.2.9.3 Key Developments | | |
        4. 5.2.9.4 SWOT Analysis | | |
        5. 5.2.9.5 Key Strategies |
    3. 5.3 Appendix | |
      1. 5.3.1 References | |
      2. 5.3.2 Related Reports 6 LIST OF FIGURES |
    4. 6.1 MARKET SYNOPSIS |
    5. 6.2 NORTH AMERICA MARKET ANALYSIS |
    6. 6.3 US MARKET ANALYSIS BY TYPE |
    7. 6.4 US MARKET ANALYSIS BY ACTIVE INGREDIENTS |
    8. 6.5 US MARKET ANALYSIS BY FORMULATION |
    9. 6.6 US MARKET ANALYSIS BY END USE |
    10. 6.7 CANADA MARKET ANALYSIS BY TYPE |
    11. 6.8 CANADA MARKET ANALYSIS BY ACTIVE INGREDIENTS |
    12. 6.9 CANADA MARKET ANALYSIS BY FORMULATION |
    13. 6.10 CANADA MARKET ANALYSIS BY END USE |
    14. 6.11 EUROPE MARKET ANALYSIS |
    15. 6.12 GERMANY MARKET ANALYSIS BY TYPE |
    16. 6.13 GERMANY MARKET ANALYSIS BY ACTIVE INGREDIENTS |
    17. 6.14 GERMANY MARKET ANALYSIS BY FORMULATION |
    18. 6.15 GERMANY MARKET ANALYSIS BY END USE |
    19. 6.16 UK MARKET ANALYSIS BY TYPE |
    20. 6.17 UK MARKET ANALYSIS BY ACTIVE INGREDIENTS |
    21. 6.18 UK MARKET ANALYSIS BY FORMULATION |
    22. 6.19 UK MARKET ANALYSIS BY END USE |
    23. 6.20 FRANCE MARKET ANALYSIS BY TYPE |
    24. 6.21 FRANCE MARKET ANALYSIS BY ACTIVE INGREDIENTS |
    25. 6.22 FRANCE MARKET ANALYSIS BY FORMULATION |
    26. 6.23 FRANCE MARKET ANALYSIS BY END USE |
    27. 6.24 RUSSIA MARKET ANALYSIS BY TYPE |
    28. 6.25 RUSSIA MARKET ANALYSIS BY ACTIVE INGREDIENTS |
    29. 6.26 RUSSIA MARKET ANALYSIS BY FORMULATION |
    30. 6.27 RUSSIA MARKET ANALYSIS BY END USE |
    31. 6.28 ITALY MARKET ANALYSIS BY TYPE |
    32. 6.29 ITALY MARKET ANALYSIS BY ACTIVE INGREDIENTS |
    33. 6.30 ITALY MARKET ANALYSIS BY FORMULATION |
    34. 6.31 ITALY MARKET ANALYSIS BY END USE |
    35. 6.32 SPAIN MARKET ANALYSIS BY TYPE |
    36. 6.33 SPAIN MARKET ANALYSIS BY ACTIVE INGREDIENTS |
    37. 6.34 SPAIN MARKET ANALYSIS BY FORMULATION |
    38. 6.35 SPAIN MARKET ANALYSIS BY END USE |
    39. 6.36 REST OF EUROPE MARKET ANALYSIS BY TYPE |
    40. 6.37 REST OF EUROPE MARKET ANALYSIS BY ACTIVE INGREDIENTS |
    41. 6.38 REST OF EUROPE MARKET ANALYSIS BY FORMULATION |
    42. 6.39 REST OF EUROPE MARKET ANALYSIS BY END USE |
    43. 6.40 APAC MARKET ANALYSIS |
    44. 6.41 CHINA MARKET ANALYSIS BY TYPE |
    45. 6.42 CHINA MARKET ANALYSIS BY ACTIVE INGREDIENTS |
    46. 6.43 CHINA MARKET ANALYSIS BY FORMULATION |
    47. 6.44 CHINA MARKET ANALYSIS BY END USE |
    48. 6.45 INDIA MARKET ANALYSIS BY TYPE |
    49. 6.46 INDIA MARKET ANALYSIS BY ACTIVE INGREDIENTS |
    50. 6.47 INDIA MARKET ANALYSIS BY FORMULATION |
    51. 6.48 INDIA MARKET ANALYSIS BY END USE |
    52. 6.49 JAPAN MARKET ANALYSIS BY TYPE |
    53. 6.50 JAPAN MARKET ANALYSIS BY ACTIVE INGREDIENTS |
    54. 6.51 JAPAN MARKET ANALYSIS BY FORMULATION |
    55. 6.52 JAPAN MARKET ANALYSIS BY END USE |
    56. 6.53 SOUTH KOREA MARKET ANALYSIS BY TYPE |
    57. 6.54 SOUTH KOREA MARKET ANALYSIS BY ACTIVE INGREDIENTS |
    58. 6.55 SOUTH KOREA MARKET ANALYSIS BY FORMULATION |
    59. 6.56 SOUTH KOREA MARKET ANALYSIS BY END USE |
    60. 6.57 MALAYSIA MARKET ANALYSIS BY TYPE |
    61. 6.58 MALAYSIA MARKET ANALYSIS BY ACTIVE INGREDIENTS |
    62. 6.59 MALAYSIA MARKET ANALYSIS BY FORMULATION |
    63. 6.60 MALAYSIA MARKET ANALYSIS BY END USE |
    64. 6.61 THAILAND MARKET ANALYSIS BY TYPE |
    65. 6.62 THAILAND MARKET ANALYSIS BY ACTIVE INGREDIENTS |
    66. 6.63 THAILAND MARKET ANALYSIS BY FORMULATION |
    67. 6.64 THAILAND MARKET ANALYSIS BY END USE |
    68. 6.65 INDONESIA MARKET ANALYSIS BY TYPE |
    69. 6.66 INDONESIA MARKET ANALYSIS BY ACTIVE INGREDIENTS |
    70. 6.67 INDONESIA MARKET ANALYSIS BY FORMULATION |
    71. 6.68 INDONESIA MARKET ANALYSIS BY END USE |
    72. 6.69 REST OF APAC MARKET ANALYSIS BY TYPE |
    73. 6.70 REST OF APAC MARKET ANALYSIS BY ACTIVE INGREDIENTS |
    74. 6.71 REST OF APAC MARKET ANALYSIS BY FORMULATION |
    75. 6.72 REST OF APAC MARKET ANALYSIS BY END USE |
    76. 6.73 SOUTH AMERICA MARKET ANALYSIS |
    77. 6.74 BRAZIL MARKET ANALYSIS BY TYPE |
    78. 6.75 BRAZIL MARKET ANALYSIS BY ACTIVE INGREDIENTS |
    79. 6.76 BRAZIL MARKET ANALYSIS BY FORMULATION |
    80. 6.77 BRAZIL MARKET ANALYSIS BY END USE |
    81. 6.78 MEXICO MARKET ANALYSIS BY TYPE |
    82. 6.79 MEXICO MARKET ANALYSIS BY ACTIVE INGREDIENTS |
    83. 6.80 MEXICO MARKET ANALYSIS BY FORMULATION |
    84. 6.81 MEXICO MARKET ANALYSIS BY END USE |
    85. 6.82 ARGENTINA MARKET ANALYSIS BY TYPE |
    86. 6.83 ARGENTINA MARKET ANALYSIS BY ACTIVE INGREDIENTS |
    87. 6.84 ARGENTINA MARKET ANALYSIS BY FORMULATION |
    88. 6.85 ARGENTINA MARKET ANALYSIS BY END USE |
    89. 6.86 REST OF SOUTH AMERICA MARKET ANALYSIS BY TYPE |
    90. 6.87 REST OF SOUTH AMERICA MARKET ANALYSIS BY ACTIVE INGREDIENTS |
    91. 6.88 REST OF SOUTH AMERICA MARKET ANALYSIS BY FORMULATION |
    92. 6.89 REST OF SOUTH AMERICA MARKET ANALYSIS BY END USE |
    93. 6.90 MEA MARKET ANALYSIS |
    94. 6.91 GCC COUNTRIES MARKET ANALYSIS BY TYPE |
    95. 6.92 GCC COUNTRIES MARKET ANALYSIS BY ACTIVE INGREDIENTS |
    96. 6.93 GCC COUNTRIES MARKET ANALYSIS BY FORMULATION |
    97. 6.94 GCC COUNTRIES MARKET ANALYSIS BY END USE |
    98. 6.95 SOUTH AFRICA MARKET ANALYSIS BY TYPE |
    99. 6.96 SOUTH AFRICA MARKET ANALYSIS BY ACTIVE INGREDIENTS |
    100. 6.97 SOUTH AFRICA MARKET ANALYSIS BY FORMULATION |
    101. 6.98 SOUTH AFRICA MARKET ANALYSIS BY END USE |
    102. 6.99 REST OF MEA MARKET ANALYSIS BY TYPE |
    103. 6.100 REST OF MEA MARKET ANALYSIS BY ACTIVE INGREDIENTS |
    104. 6.101 REST OF MEA MARKET ANALYSIS BY FORMULATION |
    105. 6.102 REST OF MEA MARKET ANALYSIS BY END USE |
    106. 6.103 KEY BUYING CRITERIA OF CONSUMER AND RETAIL |
    107. 6.104 RESEARCH PROCESS OF MRFR |
    108. 6.105 DRO ANALYSIS OF CONSUMER AND RETAIL |
    109. 6.106 DRIVERS IMPACT ANALYSIS: CONSUMER AND RETAIL |
    110. 6.107 RESTRAINTS IMPACT ANALYSIS: CONSUMER AND RETAIL |
    111. 6.108 SUPPLY / VALUE CHAIN: CONSUMER AND RETAIL |
    112. 6.109 CONSUMER AND RETAIL, BY TYPE, 2024 (% SHARE) |
    113. 6.110 CONSUMER AND RETAIL, BY TYPE, 2024 TO 2035 (USD Billion) |
    114. 6.111 CONSUMER AND RETAIL, BY ACTIVE INGREDIENTS, 2024 (% SHARE) |
    115. 6.112 CONSUMER AND RETAIL, BY ACTIVE INGREDIENTS, 2024 TO 2035 (USD Billion) |
    116. 6.113 CONSUMER AND RETAIL, BY FORMULATION, 2024 (% SHARE) |
    117. 6.114 CONSUMER AND RETAIL, BY FORMULATION, 2024 TO 2035 (USD Billion) |
    118. 6.115 CONSUMER AND RETAIL, BY END USE, 2024 (% SHARE) |
    119. 6.116 CONSUMER AND RETAIL, BY END USE, 2024 TO 2035 (USD Billion) |
    120. 6.117 BENCHMARKING OF MAJOR COMPETITORS 7 LIST OF TABLES |
    121. 7.1 LIST OF ASSUMPTIONS | |
      1. 7.1.1 |
    122. 7.2 North America MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.2.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.2.2 BY ACTIVE INGREDIENTS, 2025-2035 (USD Billion) | |
      3. 7.2.3 BY FORMULATION, 2025-2035 (USD Billion) | |
      4. 7.2.4 BY END USE, 2025-2035 (USD Billion) |
    123. 7.3 US MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.3.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.3.2 BY ACTIVE INGREDIENTS, 2025-2035 (USD Billion) | |
      3. 7.3.3 BY FORMULATION, 2025-2035 (USD Billion) | |
      4. 7.3.4 BY END USE, 2025-2035 (USD Billion) |
    124. 7.4 Canada MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.4.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.4.2 BY ACTIVE INGREDIENTS, 2025-2035 (USD Billion) | |
      3. 7.4.3 BY FORMULATION, 2025-2035 (USD Billion) | |
      4. 7.4.4 BY END USE, 2025-2035 (USD Billion) |
    125. 7.5 Europe MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.5.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.5.2 BY ACTIVE INGREDIENTS, 2025-2035 (USD Billion) | |
      3. 7.5.3 BY FORMULATION, 2025-2035 (USD Billion) | |
      4. 7.5.4 BY END USE, 2025-2035 (USD Billion) |
    126. 7.6 Germany MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.6.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.6.2 BY ACTIVE INGREDIENTS, 2025-2035 (USD Billion) | |
      3. 7.6.3 BY FORMULATION, 2025-2035 (USD Billion) | |
      4. 7.6.4 BY END USE, 2025-2035 (USD Billion) |
    127. 7.7 UK MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.7.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.7.2 BY ACTIVE INGREDIENTS, 2025-2035 (USD Billion) | |
      3. 7.7.3 BY FORMULATION, 2025-2035 (USD Billion) | |
      4. 7.7.4 BY END USE, 2025-2035 (USD Billion) |
    128. 7.8 France MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.8.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.8.2 BY ACTIVE INGREDIENTS, 2025-2035 (USD Billion) | |
      3. 7.8.3 BY FORMULATION, 2025-2035 (USD Billion) | |
      4. 7.8.4 BY END USE, 2025-2035 (USD Billion) |
    129. 7.9 Russia MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.9.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.9.2 BY ACTIVE INGREDIENTS, 2025-2035 (USD Billion) | |
      3. 7.9.3 BY FORMULATION, 2025-2035 (USD Billion) | |
      4. 7.9.4 BY END USE, 2025-2035 (USD Billion) |
    130. 7.10 Italy MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.10.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.10.2 BY ACTIVE INGREDIENTS, 2025-2035 (USD Billion) | |
      3. 7.10.3 BY FORMULATION, 2025-2035 (USD Billion) | |
      4. 7.10.4 BY END USE, 2025-2035 (USD Billion) |
    131. 7.11 Spain MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.11.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.11.2 BY ACTIVE INGREDIENTS, 2025-2035 (USD Billion) | |
      3. 7.11.3 BY FORMULATION, 2025-2035 (USD Billion) | |
      4. 7.11.4 BY END USE, 2025-2035 (USD Billion) |
    132. 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.12.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.12.2 BY ACTIVE INGREDIENTS, 2025-2035 (USD Billion) | |
      3. 7.12.3 BY FORMULATION, 2025-2035 (USD Billion) | |
      4. 7.12.4 BY END USE, 2025-2035 (USD Billion) |
    133. 7.13 APAC MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.13.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.13.2 BY ACTIVE INGREDIENTS, 2025-2035 (USD Billion) | |
      3. 7.13.3 BY FORMULATION, 2025-2035 (USD Billion) | |
      4. 7.13.4 BY END USE, 2025-2035 (USD Billion) |
    134. 7.14 China MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.14.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.14.2 BY ACTIVE INGREDIENTS, 2025-2035 (USD Billion) | |
      3. 7.14.3 BY FORMULATION, 2025-2035 (USD Billion) | |
      4. 7.14.4 BY END USE, 2025-2035 (USD Billion) |
    135. 7.15 India MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.15.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.15.2 BY ACTIVE INGREDIENTS, 2025-2035 (USD Billion) | |
      3. 7.15.3 BY FORMULATION, 2025-2035 (USD Billion) | |
      4. 7.15.4 BY END USE, 2025-2035 (USD Billion) |
    136. 7.16 Japan MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.16.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.16.2 BY ACTIVE INGREDIENTS, 2025-2035 (USD Billion) | |
      3. 7.16.3 BY FORMULATION, 2025-2035 (USD Billion) | |
      4. 7.16.4 BY END USE, 2025-2035 (USD Billion) |
    137. 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.17.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.17.2 BY ACTIVE INGREDIENTS, 2025-2035 (USD Billion) | |
      3. 7.17.3 BY FORMULATION, 2025-2035 (USD Billion) | |
      4. 7.17.4 BY END USE, 2025-2035 (USD Billion) |
    138. 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.18.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.18.2 BY ACTIVE INGREDIENTS, 2025-2035 (USD Billion) | |
      3. 7.18.3 BY FORMULATION, 2025-2035 (USD Billion) | |
      4. 7.18.4 BY END USE, 2025-2035 (USD Billion) |
    139. 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.19.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.19.2 BY ACTIVE INGREDIENTS, 2025-2035 (USD Billion) | |
      3. 7.19.3 BY FORMULATION, 2025-2035 (USD Billion) | |
      4. 7.19.4 BY END USE, 2025-2035 (USD Billion) |
    140. 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.20.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.20.2 BY ACTIVE INGREDIENTS, 2025-2035 (USD Billion) | |
      3. 7.20.3 BY FORMULATION, 2025-2035 (USD Billion) | |
      4. 7.20.4 BY END USE, 2025-2035 (USD Billion) |
    141. 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.21.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.21.2 BY ACTIVE INGREDIENTS, 2025-2035 (USD Billion) | |
      3. 7.21.3 BY FORMULATION, 2025-2035 (USD Billion) | |
      4. 7.21.4 BY END USE, 2025-2035 (USD Billion) |
    142. 7.22 South America MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.22.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.22.2 BY ACTIVE INGREDIENTS, 2025-2035 (USD Billion) | |
      3. 7.22.3 BY FORMULATION, 2025-2035 (USD Billion) | |
      4. 7.22.4 BY END USE, 2025-2035 (USD Billion) |
    143. 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.23.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.23.2 BY ACTIVE INGREDIENTS, 2025-2035 (USD Billion) | |
      3. 7.23.3 BY FORMULATION, 2025-2035 (USD Billion) | |
      4. 7.23.4 BY END USE, 2025-2035 (USD Billion) |
    144. 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.24.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.24.2 BY ACTIVE INGREDIENTS, 2025-2035 (USD Billion) | |
      3. 7.24.3 BY FORMULATION, 2025-2035 (USD Billion) | |
      4. 7.24.4 BY END USE, 2025-2035 (USD Billion) |
    145. 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.25.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.25.2 BY ACTIVE INGREDIENTS, 2025-2035 (USD Billion) | |
      3. 7.25.3 BY FORMULATION, 2025-2035 (USD Billion) | |
      4. 7.25.4 BY END USE, 2025-2035 (USD Billion) |
    146. 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.26.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.26.2 BY ACTIVE INGREDIENTS, 2025-2035 (USD Billion) | |
      3. 7.26.3 BY FORMULATION, 2025-2035 (USD Billion) | |
      4. 7.26.4 BY END USE, 2025-2035 (USD Billion) |
    147. 7.27 MEA MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.27.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.27.2 BY ACTIVE INGREDIENTS, 2025-2035 (USD Billion) | |
      3. 7.27.3 BY FORMULATION, 2025-2035 (USD Billion) | |
      4. 7.27.4 BY END USE, 2025-2035 (USD Billion) |
    148. 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.28.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.28.2 BY ACTIVE INGREDIENTS, 2025-2035 (USD Billion) | |
      3. 7.28.3 BY FORMULATION, 2025-2035 (USD Billion) | |
      4. 7.28.4 BY END USE, 2025-2035 (USD Billion) |
    149. 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.29.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.29.2 BY ACTIVE INGREDIENTS, 2025-2035 (USD Billion) | |
      3. 7.29.3 BY FORMULATION, 2025-2035 (USD Billion) | |
      4. 7.29.4 BY END USE, 2025-2035 (USD Billion) |
    150. 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.30.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.30.2 BY ACTIVE INGREDIENTS, 2025-2035 (USD Billion) | |
      3. 7.30.3 BY FORMULATION, 2025-2035 (USD Billion) | |
      4. 7.30.4 BY END USE, 2025-2035 (USD Billion) |
    151. 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL | |
      1. 7.31.1 |
    152. 7.32 ACQUISITION/PARTNERSHIP | |

Mosquito Repellents Market Segmentation

Mosquito Repellents Market By Type (USD Billion, 2025-2035)

  • Sprays
  • Creams
  • Lotions
  • Granules

Mosquito Repellents Market By Active Ingredients (USD Billion, 2025-2035)

  • DEET
  • Picaridin
  • IR3535
  • Oil of Lemon Eucalyptus

Mosquito Repellents Market By Formulation (USD Billion, 2025-2035)

  • Chemical
  • Natural
  • Biopesticides

Mosquito Repellents Market By End Use (USD Billion, 2025-2035)

  • Household
  • Commercial
  • Agricultural
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.